Invitro microbial kill rate Stat analysis [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2021-12-15 12:36 (418 d 17:22 ago) – Posting: # 22697
Views: 850

Dear MGR!
Kindly find a Cross-discipline review by FDA cross-discipline review of FDA.
Kindly also review article- Clinical, Pharmacokinetic, and In Vitro Studies to Support Bioequivalence of Ophthalmic Drug Products.
Hope it may help.
Regards,
DShah

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
21 visitors (0 registered, 21 guests [including 12 identified bots]).
Forum time: 05:59 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5